JPH049325A - Beautifying and whitening cosmetic - Google Patents
Beautifying and whitening cosmeticInfo
- Publication number
- JPH049325A JPH049325A JP2112311A JP11231190A JPH049325A JP H049325 A JPH049325 A JP H049325A JP 2112311 A JP2112311 A JP 2112311A JP 11231190 A JP11231190 A JP 11231190A JP H049325 A JPH049325 A JP H049325A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- cosmetic
- derivatives
- pigmentation
- beautifying
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 25
- 230000002087 whitening effect Effects 0.000 title claims abstract description 15
- 239000000284 extract Substances 0.000 claims abstract description 18
- 239000004615 ingredient Substances 0.000 claims abstract description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 14
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 12
- 150000003839 salts Chemical class 0.000 claims abstract description 11
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims abstract description 10
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 7
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 7
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000004480 active ingredient Substances 0.000 claims abstract description 6
- 229960003471 retinol Drugs 0.000 claims abstract description 6
- 235000020944 retinol Nutrition 0.000 claims abstract description 6
- 239000011607 retinol Substances 0.000 claims abstract description 6
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims abstract description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229940055726 pantothenic acid Drugs 0.000 claims abstract description 5
- 235000019161 pantothenic acid Nutrition 0.000 claims abstract description 5
- 239000011713 pantothenic acid Substances 0.000 claims abstract description 5
- 239000011732 tocopherol Substances 0.000 claims abstract description 5
- 235000010384 tocopherol Nutrition 0.000 claims abstract description 5
- 229960001295 tocopherol Drugs 0.000 claims abstract description 5
- 229930003799 tocopherol Natural products 0.000 claims abstract description 5
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims abstract description 5
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract 4
- 235000008160 pyridoxine Nutrition 0.000 claims abstract 2
- 239000011677 pyridoxine Substances 0.000 claims abstract 2
- 229940011671 vitamin b6 Drugs 0.000 claims abstract 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 6
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 6
- 241001330002 Bambuseae Species 0.000 claims description 6
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 6
- 239000011425 bamboo Substances 0.000 claims description 6
- 230000019612 pigmentation Effects 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 13
- 239000000126 substance Substances 0.000 abstract description 5
- 206010040880 Skin irritation Diseases 0.000 abstract description 2
- 230000036556 skin irritation Effects 0.000 abstract description 2
- 231100000475 skin irritation Toxicity 0.000 abstract description 2
- 240000008397 Ganoderma lucidum Species 0.000 abstract 2
- 235000001637 Ganoderma lucidum Nutrition 0.000 abstract 2
- 241000213810 Ephelis Species 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 235000002639 sodium chloride Nutrition 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 29
- 208000012641 Pigmentation disease Diseases 0.000 description 15
- 239000000203 mixture Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 239000003205 fragrance Substances 0.000 description 8
- 240000007235 Cyanthillium patulum Species 0.000 description 7
- 239000003921 oil Substances 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000469 ethanolic extract Substances 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 5
- 239000000306 component Substances 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- -1 ascorbic acid phosphate esters Chemical class 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000005977 Ethylene Substances 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 244000183278 Nephelium litchi Species 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000012533 medium component Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- IXUATGFEVCPOOD-UHFFFAOYSA-N 2,3-dihydroxypropyl octadecanoate;octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO IXUATGFEVCPOOD-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 244000028344 Primula vulgaris Species 0.000 description 1
- 235000016311 Primula vulgaris Nutrition 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Natural products C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 1
- 241000722085 Synanceia horrida Species 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- XHRPOTDGOASDJS-UHFFFAOYSA-N cholesterol n-octadecanoate Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCCCCCCCCCCC)C2 XHRPOTDGOASDJS-UHFFFAOYSA-N 0.000 description 1
- XHRPOTDGOASDJS-XNTGVSEISA-N cholesteryl stearate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCCCC)C1 XHRPOTDGOASDJS-XNTGVSEISA-N 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 150000002168 ethanoic acid esters Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- NGPNWUWGVIIIDG-LEJBHHMKSA-L magnesium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-yl] phosphate Chemical class [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1OP([O-])([O-])=O NGPNWUWGVIIIDG-LEJBHHMKSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-N methyl undecanoic acid Natural products CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003900 succinic acid esters Chemical class 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
産業上の利用分野
本発明は、紫外線による皮膚の黒化あるいはシミ、ソバ
カスなどの皮膚の色素沈着を消失、淡色化ま1こは予防
する美白化粧料に関する。DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to a whitening cosmetic that eliminates skin darkening, age spots, freckles, and other skin pigmentation caused by ultraviolet rays, and prevents lightening of the skin.
従来、美白化粧料組成物としてはビタミンCおよびその
誘導体、あるいは還元剤、胎盤エキスなどのチロンナー
ゼ活性阻害剤を配合したものか知られている。しかしな
がら、これら従来の美白化粧料は培養細胞によるin
vitroの実験ではメラニン産生抑制などを示すもの
の、実際に皮膚に適用した場合、充分な色素沈着の消失
らしくは淡色化などの効果は得られず、また刺激性等の
副作用の問題があった。Conventionally, whitening cosmetic compositions containing vitamin C and its derivatives, reducing agents, and thyronase activity inhibitors such as placenta extract are known. However, these conventional whitening cosmetics are made using cultured cells.
Although in vitro experiments have shown that it suppresses melanin production, when it is actually applied to the skin, it does not sufficiently remove pigmentation or lighten the skin, and there are problems with side effects such as irritation.
本発明者らは、このような問題を解決し、優れた効果を
有する美白化粧料を得るべく、鋭意研究を重ねた。その
結果、本出願人の研究考が、先に皮膚の保湿や整肌等に
すぐれた効果を発揮することを見出したマンネンタケ菌
糸体培養物および/またはその抽出エキス(特開昭61
−091113号)か、特定の物質と組合わせることに
より、皮膚刺激などの副作用なしに皮膚の色素沈着の消
失や淡色化に優れf二効果を発揮することを知り、本発
明を完成するに至った。The present inventors have conducted extensive research in order to solve these problems and obtain a whitening cosmetic with excellent effects. As a result, the present applicant's research idea led to the discovery of the Mycelium mycelium culture and/or its extract (Japanese Unexamined Patent Application Publication No. 61-111), which was previously found to have excellent effects on skin moisturization and skin conditioning.
-091113) or in combination with a specific substance, it was found that the f2 effect was excellent in eliminating skin pigmentation and lightening the skin color without side effects such as skin irritation, and this led to the completion of the present invention. Ta.
本発明は、
(a)マンネンタケ菌糸体培養物エキスおよび/または
その抽出エキス、および
(b)アスコルビン酸およびその誘導体、レチノールお
よびその誘導体、ピリドキノンおよびその誘導体、パン
トテン酸およびその誘導体ならびにトコフェロールおよ
びその誘導体からなる群から選ばれる1種または2種以
上の成分を活性成分として、配合したことを特徴とする
美白化粧料を提供するものである。The present invention provides: (a) a mushroom mycelium culture extract and/or an extract thereof; and (b) ascorbic acid and its derivatives, retinol and its derivatives, pyridoquinone and its derivatives, pantothenic acid and its derivatives, and tocopherol and its derivatives. The present invention provides a whitening cosmetic composition containing one or more ingredients selected from the group consisting of:
本発明の美白化粧料に活性成分として配合するマンネン
タケ菌糸体培養物およびその抽出エキスは前記特開昭6
1−091113号に開示されるマンネンタケ菌糸体を
液体培養して得られる全培養物濃縮物、菌糸体を分離し
た培養濃縮物、分離菌糸体あるいは全培養物、培養液、
それらの濃縮物まf二は分離菌糸体の溶媒抽出物を包含
し、これらは単独でも、併用してもよい。The Bamboo shoots mycelium culture and its extract to be blended as an active ingredient in the whitening cosmetic of the present invention are disclosed in the above-mentioned Japanese Patent Application Laid-open No. 6
1-091113, a whole culture concentrate obtained by liquid culturing the C. chinensis mycelium, a culture concentrate from which the mycelium has been separated, an isolated mycelium or a whole culture, a culture solution,
These concentrates include solvent extracts of isolated mycelia, which may be used alone or in combination.
すなわち、該マンネンタケ菌糸体培養物は、マンネンタ
ケ種菌糸をグルコース0.2〜IOW/V%および小麦
胚芽02〜2 W/V%を必須成分とする液体培地中に
て培養して得られる。該培地成分として用いるグルコー
スおよび小麦胚芽は、培地成分として通常入手しうるち
のであればL)ずれでもよい。用いる種菌糸は、担子菌
類に属するヒダナシタケ目すルノコンカケ科マンネンタ
ケのものであればいずれの種菌糸であってもよい。That is, the Bamboo shoots mycelium culture is obtained by culturing the mycelium of the Bamboo shoots species in a liquid medium containing 0.2-IOW/V% glucose and 02-2% W/V wheat germ as essential components. Glucose and wheat germ used as the medium components may be any of L) as long as they are commonly available as medium components. The seed hyphae to be used may be any seed hyphae as long as they belong to the order Pygridium, which belongs to the Basidiomycetes, and the family Pyrophyceae.
培養終了後、全培養物(菌糸体と培養液の混合物)また
はそれらから菌糸体を分離した培養液を、例えば、減圧
下、40〜50℃で濃縮し、所望により乾固し、要すれ
ば濃縮乾固の前または後に、常法に従って粉砕して本発
明の化粧料に用いるマンネンタケ菌糸体培養物を得る。After completion of the cultivation, the whole culture (mixture of mycelium and culture solution) or the culture solution from which the mycelium has been separated is concentrated, for example, at 40 to 50 °C under reduced pressure, and dried if necessary. Before or after the concentration to dryness, it is pulverized in accordance with a conventional method to obtain a L. chinensis mycelium culture for use in the cosmetic composition of the present invention.
培養物からの菌糸体の分離は濾過、遠心分離なとの常法
に従って行うことができる。Separation of mycelium from the culture can be carried out according to conventional methods such as filtration and centrifugation.
分離した菌糸体は、一般に、径1〜5mmの球状を呈し
ており、これもまた、例えば、減圧下、40〜50℃で
乾燥し、粉砕し、マンネンタケ菌糸体培養物として本発
明の化粧料に用いることかできる。The separated mycelium generally has a spherical shape with a diameter of 1 to 5 mm, and this can also be dried, for example, at 40 to 50°C under reduced pressure, pulverized, and used as the cosmetic of the present invention as a culture of C. chinensis mycelium. It can be used for
前記のごとく、本発明においては、全培養物、菌糸体を
分離した培養液、それらの濃縮物または乾固物あるいは
分離した菌糸体またはその乾燥物の溶媒抽出物を用いる
こともできる。As mentioned above, in the present invention, the whole culture, the culture solution from which the mycelium has been separated, a concentrate or dried product thereof, or a solvent extract of the separated mycelium or the dried product thereof can also be used.
抽出溶媒としては、水、アルコール、クロロホルム、エ
ーテル、酢酸エチル、ベンゼン、ヘキサンおよびこれら
の混合溶媒等を用いることができるが、本発明において
は、ことに、低級−価アルコール、多価アルコールある
いはそれらの含水溶媒を用いることか好ましい。低級−
価アルコールとしては、炭素数1〜3のアルコール、例
えば、メタノール、エタノール、プロパツール等が挙げ
られ、特に、エタノールか好ましく、含水エタノール(
含水率は10〜80%、好ましくは50〜70%)が最
も好ましい。多価アルコールとしては炭素数2〜5のア
ルコール、例えば、エチレングリコール、プロピレング
リコール、l、3−ブチレングリコール、1.4−ブチ
レングリコール、グリセリン等が挙げられ、特に、ブチ
レングリコールが好ましく、含水アルコールでもよいが
、ブチレングリコール100%が最も好ましい。As the extraction solvent, water, alcohol, chloroform, ether, ethyl acetate, benzene, hexane, and mixed solvents thereof can be used, but in the present invention, lower-hydric alcohols, polyhydric alcohols, or their It is preferable to use a water-containing solvent. Low-
Examples of the alcohol include alcohols having 1 to 3 carbon atoms, such as methanol, ethanol, propatool, etc. Ethanol is particularly preferable, and hydrous ethanol (
The moisture content is most preferably 10-80%, preferably 50-70%. Examples of the polyhydric alcohol include alcohols having 2 to 5 carbon atoms, such as ethylene glycol, propylene glycol, 1,3-butylene glycol, 1,4-butylene glycol, and glycerin, with butylene glycol being particularly preferred, and hydrous alcohols. However, 100% butylene glycol is most preferred.
抽出に際しては、例えば、該培養物の乾燥物に対して3
〜20倍量(重量)、好ましくは、5〜IO倍量の溶媒
を用いて、10〜80℃、好ましくは、20〜30℃で
撹拌しながら抽出を行うことが好ましい。For extraction, for example, 3
It is preferable to carry out the extraction using ~20 times (by weight), preferably 5 to IO times the amount of solvent at 10 to 80°C, preferably 20 to 30°C with stirring.
本発明の美白化粧料中におけるマンネンタケ菌糸体培養
物の配合量は、抽出エキスとして、化粧料全量に対して
0.1重量%〜20重量%であるのか好ましい。かかる
配合量が01重量%未満であると色素沈着の淡色化効果
かなく、20重量%を超えると皮膚に対して若干刺激を
示すようになる。It is preferable that the amount of the C. chinensis mycelial culture blended in the whitening cosmetic of the present invention is 0.1% to 20% by weight as an extracted extract based on the total amount of the cosmetic. If the amount is less than 0.1% by weight, there will be no effect of lightening pigmentation, and if it exceeds 20% by weight, it will cause some irritation to the skin.
また、本発明の化粧料のもう一方の活性成分としては、
アスコルビン酸およびその塩、また;よ、アスコルビン
酸アルキルエステル、アスコルビン酸リン酸エステルの
ようなその誘導体、レチノルおよびその塩、または、パ
ルミチン酸レチノール、ビタミン油のようなその誘導体
、ピリドキノンおよびその塩、または、ンラウリン酸エ
ステル、トリパルミチン酸エステルのようなその誘導体
、パントテン酸およびその塩、または、バントテニルエ
チルエーテルのようなその誘導体、トコフェロールおよ
びその塩、または、酢酸エステル、フハク酸エステルの
ようなその誘導体が挙げられ、これらは単独でも2種以
上を併用してもよい。In addition, the other active ingredient of the cosmetic of the present invention is:
Ascorbic acid and its salts, also; its derivatives such as ascorbic acid alkyl esters, ascorbic acid phosphate esters, retinol and its salts or its derivatives such as retinol palmitate, vitamin oil, pyridoquinone and its salts, or its derivatives such as lauric acid ester, tripalmitic acid ester, pantothenic acid and its salts or its derivatives such as bantothenyl ethyl ether, tocopherol and its salts, or acetic acid ester, succinic acid ester, etc. Derivatives thereof can be mentioned, and these may be used alone or in combination of two or more kinds.
これらの物質の化粧料中における配合量は、0゜1−1
0重量%であるのが好ましい。かかる配合量が0.1重
量%未満であると、色素沈着の淡色化効果がなく、一方
、10重量%を超えると刺激性が強い。The amount of these substances in cosmetics is 0°1-1
Preferably it is 0% by weight. If the amount is less than 0.1% by weight, there will be no effect of lightening pigmentation, while if it exceeds 10% by weight, irritation will be strong.
かくして、本発明の美白化粧料は、マンネンタケ菌糸体
培養物および/またはその抽出エキスと、前記の物質と
を公知方法により所望の他の成分と合し、化粧水、化粧
用油、クリーム、乳液、パック、パウダー等の形態とし
て製造される。Thus, the whitening cosmetic composition of the present invention can be prepared by combining the L. chinensis mycelium culture and/or its extract and the above-mentioned substances with other desired ingredients by a known method to prepare a lotion, cosmetic oil, cream, or milky lotion. It is manufactured in the form of , packs, powders, etc.
他の配合成分は特に限定するものではなく、化粧料の種
類に応じ、その性能を損なわない範囲において、適宜、
公知の成分を配合することができる。Other ingredients are not particularly limited, and may be used as appropriate depending on the type of cosmetic and within the range that does not impair its performance.
Known ingredients can be blended.
寒敷軌
つぎに、実験および実施例を挙げて本発明をさらに詳し
く説明する。Next, the present invention will be explained in more detail with reference to experiments and examples.
実験
つぎに各種活性成分についてその色素沈着の消失もしく
は淡色化の作用を評価した結果を示す。Experiments Next, we will present the results of evaluating the effects of various active ingredients on eliminating pigmentation or lightening the color.
実験方法・
イングリッシュ(English)系茶色モルモットの
を部を刺毛して紫外線(UVB強度: I J /cm
’)を照射し、1週間後に色素沈着を得た。つぎに、こ
の部位にマンネンタケ菌糸体培養物の各種溶媒抽出エキ
スおよびレチノール等の活性成分をエタノールに溶解し
た検体を4週間累積塗布した。検体を塗布していない部
位(無塗布)の色素沈着度を0とし、その淡色化の度合
によって、以下に示す判定基準に従い、色素沈着度を肉
眼判定した。Experimental method: The hair of an English brown guinea pig was pricked and exposed to ultraviolet light (UVB intensity: I J /cm).
') was irradiated and pigmentation was obtained one week later. Next, samples prepared by dissolving various solvent-extracted extracts of C. chinensis mycelium culture and active ingredients such as retinol in ethanol were cumulatively applied to this site for 4 weeks. The degree of pigmentation of the area to which no specimen was applied (no application) was set as 0, and the degree of pigmentation was determined visually according to the degree of lightening according to the criteria shown below.
判定基準・
0 色素沈着の淡色化か認められない
l わずかに色素沈着の淡色化か認められる2、中程度
の色素沈着の淡色化が認められる3:顕著な色素沈着の
淡色化が認められる結果をつぎの第1表に示す。Judgment criteria: 0: No lightening or lightening of pigmentation l Slight lightening or lightening of pigmentation 2, Moderate lightening of pigmentation 3: Results in which significant lightening of pigmentation is observed are shown in Table 1 below.
第1表から明らかなごとく、いずれの場合においても、
前記の物質を併用した場合、マンネンタケ菌糸体培養物
の各抽出エキス単独の場合に比し、さらに顕著な色素沈
着の淡色化が認められた。なお、試験中、刺激等による
発赤は認められなかった。As is clear from Table 1, in any case,
When the above-mentioned substances were used in combination, a more remarkable lightening of the pigmentation was observed compared to when each extract of the C. chinensis mycelium culture was used alone. During the test, no redness due to irritation was observed.
実施例1(化粧水) つぎの処方により化粧水を製造した。Example 1 (lotion) A lotion was manufactured according to the following formulation.
成 分 配合量(重量%)マンネンタケ菌
糸体培養物−05
エタノール抽出エキス
アスコルビン酸リン酸マグネシウム塩 0,5クリセリ
ン 60エタノール
8.0ポリオキンエチレン硬化ヒマ
ン油08
パラオキノ安息香酸メチル 005クエン酸
005クエン酸ナ
トリウム 007香料
01精製水
残部精製水にグリセリン、クエン酸、クエ
ン酸ナトリウム、アスコルビン酸リン酸マグネシウム塩
を溶解した。別に、エタノールにマンネンタケ菌糸体培
養物エタノール抽出エキス乾燥物、ポリオキシエチレン
硬化ヒマシ油(60E、O,)、パラ安息香酸メチル、
香料を溶解し、前記の精製水溶液に加えて可溶化し、濾
過して化粧水を得た。Ingredients Amount (wt%): Cyrilium mycelium culture-05 Ethanol extract Magnesium ascorbic acid phosphate 0.5 Chrycerin 60 Ethanol
8.0 Polyquine ethylene hydrogenated human oil 08 Methyl paraoquinobenzoate 005 Citric acid 005 Sodium citrate 007 Fragrance
01 Purified water
Glycerin, citric acid, sodium citrate, and ascorbic acid phosphate magnesium salt were dissolved in the remaining purified water. Separately, in ethanol, dry ethanol extract of C. chinensis mycelium culture, polyoxyethylene hydrogenated castor oil (60E, O,), methyl parabenzoate,
A perfume was dissolved, added to the purified aqueous solution, solubilized, and filtered to obtain a lotion.
実施例2(化粧用油) つぎの処方により化粧用油を製造した。Example 2 (cosmetic oil) A cosmetic oil was produced according to the following formulation.
成 分 配合1[(重量%)マンネンタ
ケ菌糸体培養物1.3〜 05ブチレングリコール抽
出エキス
レチノール 0.5ステア
リン酸コレステリル 10月見草油
20スクワラン
残部スクワラノに他の成分を均一に溶解して
化粧用油を得た。Ingredients Formulation 1 [(wt%) Bamboo shoots mycelium culture 1.3-05 Butylene glycol extract Retinol 0.5 Cholesteryl stearate October Primrose oil
20 squalane
A cosmetic oil was obtained by uniformly dissolving other ingredients in the remaining squalano.
実施例3(クリーム) つぎの処方によりクリームを製造した。Example 3 (cream) A cream was manufactured according to the following formulation.
成 分
配合!!(重量%)
成分(A)
トコフェロール
サランミツロウ
セタノール
ステアリン酸
ミリスチン酸イソプロピル
ラノリン
流動パラフィン
自己乳化型モノステアリン酸
グリセリル
モノステアリン酸ポリオキン
エチレンソルビタン(20E、0.)
パラオキノ安口、香酸プロピル
吸水σQ
マンネンタケ菌糸体培養物
エタノール
パラオキノ安息香酸メチル
プロピレンクリコール
香料
0.2
精製水 残部成分(A)
を加熱溶解し、80℃に保持した。別に、香料を除く成
分(B)を加熱溶解して80℃に保ち、これに前記成分
(A)を撹拌しながら加え充分に混合した。撹拌しなが
ら冷却を行い、ついで、香料を加え、さらに冷却してク
リームを得た。Ingredient combination! ! (Weight %) Ingredients (A) Tocopherol Saran Beeswax Setanol Stearate Myristate Isopropyl Lanolin Liquid paraffin Self-emulsifying monostearate Glyceryl Monostearate Polyoquine Ethylene sorbitan (20E, 0.) Paraoquino Yasukuchi, Propyl fragrant water absorption σQ Stonegrass Mycelial culture Ethanol Para-oquinobenzoate Methyl propylene glycol Fragrance 0.2 Purified water Remaining ingredients (A)
was dissolved by heating and maintained at 80°C. Separately, component (B) excluding fragrance was dissolved by heating and maintained at 80° C., and component (A) was added thereto with stirring and thoroughly mixed. The mixture was cooled while stirring, and then a fragrance was added and further cooled to obtain a cream.
実施例4(乳液) つぎの処方により乳液を製造した。Example 4 (emulsion) A milky lotion was produced according to the following recipe.
成 分 配合量(重量%)成分(A)
パントテン酸
グリチルレチン酸ステアリル
流動パラフィン
ワセリン
ミツロウ
セスキオレイン酸ソルヒタン
成分(B)
マンネンタケ菌糸体培養物
エチレンゴリクール抽出エキス
ポリオキノエチレン
オレイルエーテル(20E○)
パラオキシ安息香酸エチル 0.2プロピレ
ングリコール 5.0カルボキシビニル
ポリマー 0.5水酸化カリウム
05香料
0.2精製水 残部成
分(A)を80℃にて加熱溶解し、別に(80℃)溶解
した香料を除く成分(B)に撹拌しながら加え、充分混
合した。ついて、撹拌しなから冷却を行い、香料を加え
、さらに冷却して乳液を得た。Ingredients Amount (wt%) Ingredient (A) Pantothenic acid, glycyrrhetinic acid, stearyl, liquid paraffin, petrolatum, beeswax, sesquioleic acid, solhitane (B), Glycyrrhiza mycelium culture, ethylene golicool extract, polyoquinoethylene oleyl ether (20E○), paraoxybenzoin Ethyl acid 0.2 Propylene glycol 5.0 Carboxyvinyl polymer 0.5 Potassium hydroxide
05 fragrance
0.2 Purified water The remaining component (A) was dissolved by heating at 80° C., and added to the separately dissolved component (B) excluding the fragrance (at 80° C.) with stirring, and thoroughly mixed. Then, the mixture was cooled without stirring, perfume was added, and the mixture was further cooled to obtain an emulsion.
実施例5(パック) つぎの処方によりパックを製造しに。Example 5 (pack) To manufacture a pack using the following recipe.
成 分 配合量(重量%)マンネンタケ菌
糸体培養物 05エタノール抽出エキス
酢酸トコフェロール 05酢酸ビニル
・スチレン共重合体 10.0ポリビニルアルコ
ール I O,0ソルピゾト
50酸化チタン
8,0カオリン 70
エタノール 50香料
20パラオキシ安慝香
酸エチル 0.2精製水
残部マンネンタケ菌糸体培養物のエタノー
ル抽出エキス、酢酸トコフェロール、香料およびエタノ
ルを均一に溶解した。これを酢酸ビニル・スチレン共重
合体、ポリビニルアルコール、ソルビット、酸化チタン
およびカオリンを均一に混和した混合物に加えた。これ
に、さらにパラオキノ安、じ香酸エチルを精製水に均一
に溶解した溶液を加え、均一に混和しパックを得た。Ingredients Amount (wt%): Bamboo shoots mycelium culture 05 Ethanol extract Tocopherol acetate 05 Vinyl acetate/styrene copolymer 10.0 Polyvinyl alcohol I O,0 Solpizoto
50 titanium oxide
8,0 Kaolin 70
Ethanol 50 fragrance
20 Ethyl paraoxybenzoate 0.2 Purified water
The remainder of the ethanol extract of the Cinnamon mycelium culture, tocopherol acetate, fragrance, and ethanol were uniformly dissolved. This was added to a homogeneous mixture of vinyl acetate-styrene copolymer, polyvinyl alcohol, sorbitol, titanium oxide, and kaolin. To this, a solution in which paraoquinoamic acid and ethyl dizoate were uniformly dissolved in purified water was added and mixed uniformly to obtain a pack.
実施例6(パウダー) っぎの処方によりパウダーを製造した。Example 6 (powder) Powder was manufactured according to the recipe.
成 分 配合量(重量%)マンネンタケ菌
糸体培養物 1030%含水エタノール抽出
エキス
ピリドキノン 02デキスト
リン 95.5タルク
2.0ステアリン酸デカグリ
セリル 10マンネンタケ菌糸体培養物の30
%含水エタノール抽出エキス、ピリドキノン、およびス
テアリン酸デカグリセリルを加熱溶解し、70°Cに保
持し、これをデキストリンおよびタルクの混合物に撹拌
しながら徐々に加えてパウダーを得た。Ingredients Quantity (wt%) Stonefish mycelium culture 1030% aqueous ethanol extract Pyridoquinone 02 Dextrin 95.5 Talc
2.0 decaglyceryl stearate 10 30 of C. chinensis mycelium culture
% water-containing ethanol extract, pyridoquinone, and decaglyceryl stearate were heated and dissolved, maintained at 70°C, and gradually added to the mixture of dextrin and talc with stirring to obtain a powder.
発明の効果
本発明の美白化粧料は、皮膚に適用することにより、刺
激性等の副作用なく、紫外線による皮膚の黒化あるいは
色素沈着を消失、淡色化もしくは予防し、優れた美白効
果を特徴するEffects of the Invention The whitening cosmetic of the present invention, when applied to the skin, eliminates, lightens, or prevents darkening or pigmentation of the skin caused by ultraviolet rays without side effects such as irritation, and is characterized by an excellent whitening effect.
Claims (1)
の抽出エキス、および (b)アスコルビン酸およびその塩あるいはその誘導体
、レチノールおよびその塩あるいはその誘導体、ピリド
キシンおよびその塩あるいはその誘導体、パントテン酸
およびその塩あるいはその誘導体ならびにトコフェロー
ルおよびその塩あるいはその誘導体からなる群から選ば
れる1種または2種以上の成分を活性成分として配合し
たことを特徴とする美白化粧料。[Scope of Claims] 1. (a) Bamboo shoots mycelium culture and/or its extract, and (b) ascorbic acid and its salts or its derivatives, retinol and its salts or its derivatives, pyridoxine and its salts or its derivatives. 1. A whitening cosmetic comprising, as an active ingredient, one or more ingredients selected from the group consisting of derivatives, pantothenic acid and its salts or its derivatives, and tocopherol and its salts or its derivatives.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2112311A JPH049325A (en) | 1990-04-27 | 1990-04-27 | Beautifying and whitening cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2112311A JPH049325A (en) | 1990-04-27 | 1990-04-27 | Beautifying and whitening cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH049325A true JPH049325A (en) | 1992-01-14 |
Family
ID=14583501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2112311A Pending JPH049325A (en) | 1990-04-27 | 1990-04-27 | Beautifying and whitening cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH049325A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994007462A1 (en) * | 1992-09-30 | 1994-04-14 | Unilever Plc | Cosmetic composition containing retinol |
WO1994009756A1 (en) * | 1992-11-05 | 1994-05-11 | Unilever Plc | Retinol containing cosmetic composition |
JP2006045087A (en) * | 2004-08-02 | 2006-02-16 | Kanebo Cosmetics Inc | beta4 INTEGRIN PRODUCTION PROMOTER AND SKIN-BEAUTIFYING COSMETIC |
KR100581374B1 (en) * | 1999-04-22 | 2006-05-24 | 주식회사 엘지생활건강 | Composition of cosmetics comprising effect of improving subdued skin color |
US7332152B2 (en) | 2003-11-06 | 2008-02-19 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Cosmetic composition |
-
1990
- 1990-04-27 JP JP2112311A patent/JPH049325A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994007462A1 (en) * | 1992-09-30 | 1994-04-14 | Unilever Plc | Cosmetic composition containing retinol |
US5705144A (en) * | 1992-09-30 | 1998-01-06 | Unilever Patent Holdings B.V. | Cosmetic composition containing retinol and dioic acid |
WO1994009756A1 (en) * | 1992-11-05 | 1994-05-11 | Unilever Plc | Retinol containing cosmetic composition |
KR100581374B1 (en) * | 1999-04-22 | 2006-05-24 | 주식회사 엘지생활건강 | Composition of cosmetics comprising effect of improving subdued skin color |
US7332152B2 (en) | 2003-11-06 | 2008-02-19 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Cosmetic composition |
JP2006045087A (en) * | 2004-08-02 | 2006-02-16 | Kanebo Cosmetics Inc | beta4 INTEGRIN PRODUCTION PROMOTER AND SKIN-BEAUTIFYING COSMETIC |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60306565T2 (en) | Anti-cancer compositions for topical use | |
JP4567278B2 (en) | Skin cosmetics | |
JPH07126149A (en) | Cosmetic composition for beautifying and whitening | |
JPH05186324A (en) | Beautifying cosmetic | |
JPH049316A (en) | Whitening cosmetic | |
WO2006101119A1 (en) | Collagen synthesis promoter | |
JP4906179B2 (en) | Topical skin preparation | |
JP2001122733A (en) | Catalase production-promoting preparation and skin preparation for external use containing the same | |
JPH049325A (en) | Beautifying and whitening cosmetic | |
JP2001261548A (en) | Skin care preparation | |
JPH06128142A (en) | External agent for skin | |
JP2001114636A (en) | Hyaluronic acid production and catalase production promoting agent, fibroblast activating agent and skin lotion | |
JPH03275609A (en) | Skin cosmetic | |
JPH049315A (en) | Whitening cosmetic | |
JPH05345705A (en) | Skin-beautifying cosmetic composition | |
JPH05201847A (en) | Skin-beautifying cosmetic | |
JPH09291021A (en) | Beautifying and whitening cosmetic | |
JPH07258063A (en) | External preparation for skin | |
JPH049321A (en) | Beautifying and whitening cosmetic | |
JP3822959B2 (en) | Anti-aging skin external preparation | |
JPH11246424A (en) | Tyrosinase inhibitor and its production | |
JP4610705B2 (en) | Topical skin preparation | |
JP3105664B2 (en) | External preparation for skin | |
JP4076477B2 (en) | Skin preparation | |
JP2002145752A (en) | Skin care preparation and composition for skin care preparation |